Pharmacologic effects of anisodamine
Zhonghua yi xue za zhi 53(5): 269-273
1973
ISSN/ISBN: 0376-2491 PMID: 4633885 Document Number: 66630
Document emailed within 1 workday
Related Documents
Sun, R.Y. 1982: Effects of anisodamine on pulmonary circulation and function of the dog in shock Zhonghua Yi Xue Za Zhi 62(8): 458-460Sleptsova, S.I. 1987: Effects of various pharmacologic and non-pharmacologic agents on the mother and fetus (data for the health promotion propaganda) Akusherstvo i Ginekologiia 12: 68-71
Yue, T.L.; Chen, X.S.; Li, J. 1989: Effects of anisodamine on the metabolism of arachidonic acid by washed rat platelets Yao Xue Xue Bao 24(9): 647-652
Luo, G.; Shen, C.; Yang, X.; Zhang, Y. 1988: Effects of ligustrazine and anisodamine on rabbit whole blood viscosity and erythrocyte deformability Chinese Medical Journal 101(1): 48-51
Luo, G. 1987: Effects of ligustrazin and anisodamine on whole blood viscosity and erythrocyte deformability in rabbits Zhonghua Yi Xue Za Zhi 67(11): 607-609
Dai, S.; Cheng, J.; Sun, R.; Duan, J.; Yuan, Q.; Sun, Y.; Yan, Y.; Xue, Q. 1993: Hemodynamic and nonhemodynamic mechanisms of experimental pulmonary edema in rats and the effects of anisodamine and tetramethylpyrazine--estimation of blood gas analysis, RBC superoxide dismutase and prostaglandin E2 in plasma and bronchoalveolar lavage (Part 3) Chinese Medical Sciences Journal 8(4): 210-214
Ohnuma, T.; Roboz, J.; Waxman, S.; Mandel, E.; Martin, D.S.; Holland, J.F. 1980: Clinical pharmacologic effects of thymidine plus 5-FU Cancer Treatment Reports 64(12): 1169-1177
Seeman, M.V. 1981: Pharmacologic features and effects of neuroleptics Canadian Medical Association Journal 125(8): 821-826
Martínková, J. 1991: Pharmacologic effects on portal circulation Casopis Lekaru Ceskych 130(12): 374-378
Costa, F.V. 1988: Clinical pharmacologic aspects of mepartricin. Possible pharmacologic interference with digitaloids and anticoagulants Minerva Urologica e Nefrologica 40(2 Suppl): 5-6
Németh, L.; Institóris, L.; Somfai, S.; Gál, F.; Pályi, I.; Sugár, J.; Csuka, O.; Szentirmay, Z.; Kellner, B. 1972: Pharmacologic and antitumor effects of 1,2:5,6-dianhydrogalactitol (NSC-132313) Cancer ChemoTherapy Reports 56(5): 593-602
Maynard, J.R.; Fintel, D.J.; Pitlick, F.A.; Nemerson, Y. 1976: Tissue factor in cultured cells: pharmacologic effects Laboratory Investigation; A Journal of Technical Methods and Pathology 35(6): 550-557
Bifarini, G.; Trabalza, N.; Falconi, S.; Malà, L.; Favetta, P. 1990: Possible effects of pharmacologic prophylaxis for Mendelson's syndrome on newborns Minerva Anestesiologica 56(12): 1447-1450
Cheav, S.L.; Chalfoun-Mounayar, A.; Foussard-Blanpin, O. 1989: Pharmacologic effects of glycerolformal on the central nervous system Annales Pharmaceutiques Francaises 47(6): 353-360
Zuskin, E.; Mustajbegović, J.; Sitar-Srebocan, V. 1997: Pharmacologic study of the effects of the components of beer in vitro Lijecnicki Vjesnik 119(3-4): 103-105
Shen, G.L.; Zhang, Y.; Yu, R.Q. 1985: Studies on PVC membrane anisodamine selective electrodes Yao Xue Xue Bao 20(2): 151-154
Wang, Z.W. 1984: Observation on anisodamine treatment of the toxemia of pregnancy Zhonghua Fu Chan Ke Za Zhi 19(3): 142-144; 190
Blaschke, T.F.; Melmon, K.L. 1974: Clinical significance of pharmacologic effects of roentgen contrast media Der Internist 15(8): 439-443
Santarelli, L.; Gobbi, G.; Blier, P.; Hen, R.é 2002: Behavioral and physiologic effects of genetic or pharmacologic inactivation of the substance P receptor (NK1) Journal of Clinical Psychiatry 63(Suppl 11): 11-17
Gormus, B.J.; Basara, M.L.; Arneson, M.A.; Kaplan, M.E. 1980: Capping of mouse spleen lymphocyte C3 receptors: effects of pharmacologic agents Journal of Immunology 124(6): 2747-2753